Nick Cruden

Medicine & Life Sciences

1. Bradykinin 100%
2. Heart Failure 91%
3. Blood Vessels 80%
4. Kinins 77%
5. Myocardial Infarction 61%
6. Vasodilation 60%
7. Peptidyl-Dipeptidase A 56%
8. Pyr(1)-apelin 13 51%
9. Forearm 49%
10. Reperfusion Injury 47%
11. Tissue Plasminogen Activator 46%
12. icatibant 44%
13. Apelin 44%
14. Endothelium 40%
15. Coronary Angiography 37%
16. CD40 Ligand 37%
17. Transcatheter Aortic Valve Replacement 36%
18. Endothelial Progenitor Cells 36%
19. Radial Artery 36%
20. Angiotensin-Converting Enzyme Inhibitors 35%
21. ST Elevation Myocardial Infarction 33%
22. Positron-Emission Tomography 32%
23. Nitric Oxide Synthase Type II 31%
24. Ischemic Preconditioning 31%
25. Cardiac Catheterization 31%
26. Vascular System Injuries 30%
27. rotigaptide 30%
28. Tomography 30%
29. Carboxypeptidase B2 29%
30. Stents 28%
31. Nitroprusside 28%
32. Cortisone 27%
33. Clinical Trials 26%
34. Hydrocortisone 26%
35. Heart 24%
36. Thrombosis 24%
37. Endothelin A Receptor Antagonists 22%
38. Perfusion 22%
39. Optical Coherence Tomography 22%
40. Angioplasty 22%
41. Aortic Valve 22%
42. Endothelial Cells 22%
43. Atherosclerotic Plaques 22%
44. CT protocol 21%
45. Endothelin B Receptors 21%
46. Endothelin-1 21%
47. Systolic Murmurs 21%
48. Coronary Artery Disease 20%
49. Mineralocorticoid Receptor Antagonists 20%
50. Nitric Oxide 19%